PMID- 37056772 OWN - NLM STAT- MEDLINE DCOM- 20230417 LR - 20230417 IS - 1664-3224 (Electronic) IS - 1664-3224 (Linking) VI - 14 DP - 2023 TI - Lipoteichoic acid of Streptococcus gordonii as a negative regulator of human dendritic cell activation. PG - 1056949 LID - 10.3389/fimmu.2023.1056949 [doi] LID - 1056949 AB - Streptococcus gordonii, an opportunistic Gram-positive bacterium, causes an infective endocarditis that could be fatal to human health. Dendritic cells (DCs) are known to be involved in disease progression and immune responses in S. gordonii infection. Since lipoteichoic acid (LTA) is a representative virulence factor of S. gordonii, we here investigated its role in the activation of human DCs stimulated with LTA-deficient (DeltaltaS) S. gordonii or S. gordonii LTA. DCs were differentiated from human blood-derived monocytes in the presence of GM-CSF and IL-4 for 6 days. DCs treated with heat-killed DeltaltaS S. gordonii (DeltaltaS HKSG) showed relatively higher binding and phagocytic activities than those treated with heat-killed wild-type S. gordonii (wild-type HKSG). Furthermore, DeltaltaS HKSG was superior to wild-type HKSG in inducing phenotypic maturation markers including CD80, CD83, CD86, PD-L1, and PD-L2, antigen-presenting molecule MHC class II, and proinflammatory cytokines such as TNF-alpha and IL-6. Concomitantly, DCs treated with the DeltaltaS HKSG induced better T cell activities, including proliferation and activation marker (CD25) expression, than those treated with the wild-type. LTA, but not lipoproteins, isolated from S. gordonii weakly activated TLR2 and barely affected the expression of phenotypic maturation markers or cytokines in DCs. Collectively, these results demonstrated that LTA is not a major immuno-stimulating agent of S. gordonii but rather it interferes with bacteria-induced DC maturation, suggesting its potential role in immune evasion. CI - Copyright (c) 2023 Kim, Im, Ko, Lee, Seo, Yun and Han. FAU - Kim, Sun Kyung AU - Kim SK AD - Department of Oral Microbiology and Immunology, and Dental Research Institute, School of Dentistry, Seoul National University, Seoul, Republic of Korea. FAU - Im, Jintaek AU - Im J AD - Department of Oral Microbiology and Immunology, and Dental Research Institute, School of Dentistry, Seoul National University, Seoul, Republic of Korea. FAU - Ko, Eun Byeol AU - Ko EB AD - Department of Oral Microbiology and Immunology, and Dental Research Institute, School of Dentistry, Seoul National University, Seoul, Republic of Korea. FAU - Lee, Dongwook AU - Lee D AD - Department of Oral Microbiology and Immunology, and Dental Research Institute, School of Dentistry, Seoul National University, Seoul, Republic of Korea. FAU - Seo, Ho Seong AU - Seo HS AD - Research Division for Biotechnology, Korea Atomic Energy Research Institute, Jeongeup, Republic of Korea. FAU - Yun, Cheol-Heui AU - Yun CH AD - Department of Agricultural Biotechnology, and Research Institute of Agriculture and Life Sciences, Seoul National University, Seoul, Republic of Korea. AD - Institutes of Green-bio Science and Technology, Seoul National University, Pyeongchang, Gangwon-do, Republic of Korea. AD - Interdisciplinary Programs in Agricultural Genomics, Seoul National University, Seoul, Republic of Korea. FAU - Han, Seung Hyun AU - Han SH AD - Department of Oral Microbiology and Immunology, and Dental Research Institute, School of Dentistry, Seoul National University, Seoul, Republic of Korea. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20230328 PL - Switzerland TA - Front Immunol JT - Frontiers in immunology JID - 101560960 RN - 56411-57-5 (lipoteichoic acid) RN - 0 (Cytokines) RN - 0 (Lipopolysaccharides) SB - IM MH - Humans MH - *Streptococcus gordonii/metabolism MH - *Cytokines/metabolism MH - Lipopolysaccharides/pharmacology/metabolism MH - Dendritic Cells PMC - PMC10086370 OTO - NOTNLM OT - Streptococcus gordonii OT - T cell activation OT - dendritic cell OT - immune evasion OT - lipoprotein OT - lipoteichoic acid COIS- The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. EDAT- 2023/04/15 06:00 MHDA- 2023/04/17 06:41 PMCR- 2023/01/01 CRDT- 2023/04/14 02:33 PHST- 2022/09/29 00:00 [received] PHST- 2023/03/13 00:00 [accepted] PHST- 2023/04/17 06:41 [medline] PHST- 2023/04/14 02:33 [entrez] PHST- 2023/04/15 06:00 [pubmed] PHST- 2023/01/01 00:00 [pmc-release] AID - 10.3389/fimmu.2023.1056949 [doi] PST - epublish SO - Front Immunol. 2023 Mar 28;14:1056949. doi: 10.3389/fimmu.2023.1056949. eCollection 2023.